Meet the 2020 Laureates: Richard J. Santen, MD

santen

Richard J. Santen, MD

Fred Conrad Koch Lifetime Achievement Award

Richard J. Santen, MD, is professor of medicine at the University of Virginia and a former president of the Endocrine Society. His impressive clinical and research career has focused on both prostate and breast cancer. His pioneering work led to the development of first, second, and third generation aromatase inhibitors for the treatment of hormone-dependent breast cancer. His laboratory has continued with seminal publications on the study of the mechanisms relating estrogens to breast cancer and the biology and natural history of endocrine-dependent forms of breast cancer.

He has published over 400 manuscripts and chapters, predominantly related to the role that estrogen plays in breast cancer development. His expertise in estrogens led to a strong clinical interest in the treatment of menopause and to his selection by the Endocrine Society to write a definitive Scientific Statement on this topic. He enlisted 34 internationally diverse, expert clinicians to write this treatise.

For his work in the development of aromatase inhibitors, now standard of care for hormone dependent breast cancer, he received the Susan Komen Foundation Brinker International Award for breast cancer clinical research in 1993. Other awards include the American Association of Clinical Chemistry Distinguished Science Award, the Robert H. Williams Distinguished Leadership Award of the Endocrine Society, and the William L. McGuire Memorial Lectureship Award for breast cancer.

During his illustrious career, Dr. Santen has been a major contributor to the Endocrine Society, serving as chair of the Finance Committee, spearheading a financial plan to secure the long-term stability of the Endocrine Society, initiating the International Scholars program of the Endocrine Society, and, as president of the Endocrine Society, leading an initiative to support the next generation of endocrinologists. Recognized as a leading clinical endocrinologist, Santen’s achievements have spanned the clinical, research, teaching, and administrative spectrum.

You may also like

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…

  • Endocrine Society Elects Wysham as 2021-2022 President

    Five endocrinologists to join Board of Directors Endocrine Society members have elected Carol H. Wysham, MD, to serve as the organization’s President for the 2021-2022 term. Wysham is an endocrinologist at Rockwood/MultiCare Health Systems in Spokane, Wash., and Clinical Professor of Medicine at the University of Washington. She will serve as President-Elect for a year…

Find more in